Skip to main content

Monia Brett P's Form 4 filing

Ionis Pharmaceuticals Inc (IONS) · filed Mar 11, 2026

Accession no.
0000874015-26-000143
Filed
Mar 11, 2026
Trade date
Mar 9-10, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 8 non-derivative transactions and 3 derivative transactions. Open-market sales total $12.1M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Monia Brett PCIK 0001537529Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 9, 2026Common StockMOption exerciseAcquired+40,822$60.89+$2,485,651.58295,803Direct
Mar 9, 2026Common StockMOption exerciseAcquired+73,529$60.89+$4,477,180.81369,332Direct
Mar 9, 2026Common StockSSaleDisposed−7,382$74.11−$547,080.02361,950Direct
Mar 9, 2026Common StockSSaleDisposed−117,604$75.26−$8,850,877.04244,346Direct
Mar 9, 2026Common StockSSaleDisposed−1,684$75.58−$127,276.72242,662Direct
Mar 10, 2026Common StockMOption exerciseAcquired+34,103$60.89+$2,076,531.67276,765Direct
Mar 10, 2026Common StockSSaleDisposed−16,512$75.47−$1,246,160.64260,253Direct
Mar 10, 2026Common StockSSaleDisposed−17,591$76.34−$1,342,896.94242,662Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 9, 2026Common StockMOption exerciseDisposed−40,822$0.00$0107,632Direct
Mar 9, 2026Common StockMOption exerciseDisposed−73,529$0.00$034,103Direct
Mar 10, 2026Common StockMOption exerciseDisposed−34,103$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)